Clinical trial reports

Which Endpoints Are Measured Most Often in European Neurology Phase II & III Trials?
From PFS to Recurrence-Free Survival: How Phase III Breast Cancer Trials Structure Endpoints in Europe
Where Is EU Site Activity Concentrated in Phase II/III Upper GI Cancer Trials?
Which Endpoints Are Measured Most Often in European Phase II & III Gastric, GEJ, and Esophageal Cancer Trials?
Which CROs Are Most Active in European Haematology Phase III Trials, and Where Is Support Needed Most?
What Shapes Phase II Respiratory CTIS Timelines and Delays?
Which EU Sites Lead Gastric, GEJ and Esophageal Cancer Phase 2 and Phase 3 Trials?
How Fast Are Phase I Immunology CTIS Reviews and What Shapes Delay?
Which European Sites Lead Phase III Psychiatry Trials?
Is Overall Survival Still the Primary Endpoint Anchor Across European Phase III Oncology Trials?
When Do Phase III Oncology–Haematology Trials Use PFS-Family Primary Endpoints?
Which EU/EEA Sites Lead Glioblastoma and Glioma Phase I–III Trial Participation?